2007 (v1)
Publication
Objectives: Primary objective: to assess ablative efficacy and tolerability of short-schedule intravesical gemcitabine for intact, low- and intermediate-risk, recurrent superficial bladder tumours. Secondary objective: to assess effect on prophylaxis. Methods: Patients with a diagnosis of recurrence and a history of previous superficial, low-...
Uploaded on: April 14, 2023